DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20200995

Hysteroscopic treatment of cervical pregnancy: case report

Aarón Jiménez Valdez, Sara Elia Hernadez Flores, Jorge Arturo Barbabosa Vilchis, Claudia Meixueiro Calderon

Abstract


Of ectopic pregnancies, cervical implantation pregnancy is an exceptional entity, corresponding to less than 1% of ectopic pregnancies. With an incidence calculated at 1: 2500 to 1: 12,000 pregnancies. The risk factors for cervical pregnancy are the same as for other ectopic pregnancies. This entity, a difference from tubaric pregnancy where bleeding is within the peritoneal cavity, the main risk is incoercible vaginal bleeding, which usually ends in a hysterectomy, which limits the reproductive future of patients. There are currently no established criteria for candidates for medical versus surgical treatment. This case reports a case of cervical ectopic pregnancy, treated with Methotrexate, and culminating with hysteroscopy resection.


Keywords


Cervical implantation, Ectopic pregnancies, Hysteroscopy, Methotrexate

Full Text:

PDF

References


Brady PC. New evidence to guide ectopic pregnancy diagnosis and management. Obstet Gynecol Surv. 2017;72(10):618-25.

Bielak A, Hincz P, Brot A, Wojciechowska E, Borowski D, Kozarzewski M, et al. Cervical ectopic pregnancy: a case report. Ginekologia Polska. 2006;877(11):881-4.

Anate M, Ismaila GA. Cervical ectopic pregnancy: a case report. West African J Med. 1996;15(2):123-5.

Levin G, Dior UP, Shushan A, Gilad R, Benshushan A, Rottenstreich A. Risk factors for recurrent ectopic pregnancy following single-dose methotrexate treatment. Eur J Contracept Reprod Health Care. 2019;24(4):294-8.

Yang C, Cai J, Geng Y, Gao Y. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis. Reproduct Bio Med Online. 2017;34(4):383-91.

Ohannessian A, Crochet P, Courbiere B, Gnisci A, Agostini A. Methotrexate treatment for ectopic pregnancy after assisted reproductive technology: A case-control study. Gynecol Obstet Fertil. 2016;44(6):341-4.

Marret H, Fauconnier A, Dubernard G, Misme H, Lagarce L, Lesavre M, et al. Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF. Eur J Obstet Gynecol Reprod Biol. 2016;205:105-9.

Piccioni MG, Framarino-Dei-Malatesta M, Polidori NF, Marcoccia E. Cervical ectopic pregnancy treated with systemic methotrexate and following successful term pregnancy: case report. J Obstet Gynaecol. 2015;35(6):654-5.